Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
1.970
+0.020 (1.03%)
At close: Mar 31, 2025, 4:00 PM
1.983
+0.013 (0.67%)
After-hours: Mar 31, 2025, 6:45 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $29.91 million as of March 31, 2025. Its market cap has decreased by -47.56% in one year.
Market Cap
29.91M
Enterprise Value
27.45M
1-Year Change
-47.56%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $29.91M, a decrease of -54.70%. That is a compound annual growth rate of -36.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 29.91M | 12.50% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |